|
Orthologous residues
|
|
p53 (human): S15‑p, p53 (mouse): S15‑p, p53 iso2 (mouse): S18‑p, p53 (rat): S15‑p, p53 (rabbit): S15‑p, p53 (monkey): S15‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), RKO (intestinal)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
hypoxia
|
|
|
|
increase
|
|
|
ionizing radiation
|
|
|
|
increase
|
|
|
UV
|
|
|
|
increase
|
|
|
desferoxamine
|
|
|
|
increase
|
|
|
hydroxyurea
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
protein stabilization
|
|
Effect of modification (process):
cell cycle regulation
|